Kimia Therapeutics
Kimia Therapeutics is a Berkeley-based drug discovery company building a chemical atlas for treating human disease through precision chemistry and machine learning.
Last updated October 5, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Kimia Therapeutics is a drug discovery company based in Berkeley, California, United States. According to its official website, the company focuses on "building chemical maps to treat human disease," positioning itself at the intersection of precision chemistry and machine learning. Kimia Therapeutics is not a traditional pharmaceutical manufacturer, but a research-driven organization committed to transforming drug discovery by uncovering new biological insights. The company's stated mission centers on improving patient outcomes. Its scientific and technological approach combines precision chemistry with machine learning to systematically map chemical space related to human disease. This concept of chemical mapping suggests a platform-oriented strategy: rather than pursuing a single therapeutic program, Kimia Therapeutics appears to be building foundational tools and data assets designed to accelerate the identification and development of new therapies. Kimia Therapeutics is headquartered in Berkeley, California, within the San Francisco Bay Area life sciences ecosystem. The company operates primarily in the United States. Its official website describes corporate values that emphasize prioritizing patient needs, innovating together, acting with respect and integrity, pursuing excellence, and celebrating success. These values reflect a collaborative, data-driven culture oriented toward long-term scientific ambitions. As a private company, Kimia Therapeutics does not appear to have publicly traded securities. Details regarding its founding year, founders, ownership structure, and specific product pipeline are not included in the provided evidence. The company is currently operational and continues to advance its mission to transform drug discovery through an integrated chemistry and machine learning platform.
History
Kimia Therapeutics is a drug discovery company based in Berkeley, California, in the United States. Publicly available information about the company is limited, but its official website and Wikidata entry confirm its existence as a commercial entity focused on therapeutic research. The company describes its core endeavor as "generating a chemical atlas for treating human disease." This mission statement indicates that Kimia Therapeutics is engaged in building a systematic, data-rich map of chemical matter relevant to human biology and disease. Such an approach typically involves generating large libraries of chemical compounds, screening them against biological targets, and using computational methods to extract patterns that can guide the design of new medicines. A central element of the company's strategy is the integration of precision chemistry with machine learning. According to its Science & Tech page, Kimia Therapeutics strives to "transform drug discovery by uncovering novel biological insights through precision chemistry and machine learning." This combination suggests that the company uses advanced computational models to analyze chemical and biological data, potentially accelerating the identification of promising drug candidates and reducing the time and cost associated with traditional discovery methods. The company's stated values emphasize patient-centricity, collaboration, integrity, excellence, and celebration of success. These values are presented as guiding principles for its team and partners. The emphasis on "rational data-driven decisions" aligns with its technology-focused approach. Kimia Therapeutics is headquartered in Berkeley, California, placing it within one of the world's leading hubs for biotechnology and pharmaceutical innovation. The company operates primarily in the United States. As of the available evidence, it is a privately held company, and no information about founders, founding date, funding rounds, or specific pipeline programs is provided. The company remains active, with its website serving as the primary public source of information about its mission and approach.
Products and positioning
A drug discovery company integrating precision chemistry and machine learning to build a chemical atlas for treating human disease.
Product categories. therapeutics
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/kimia-therapeutics · Editorial policy · How profiles are compiled